My IDSA Contact Us
IDSA NewsPrint-Friendly Newsletter
Forward to a Friend
Search Back Issues
 
Education & Training Resources Practice Guidelines Journals & Publications Policy & Advocacy Meetings About IDSA
July/August 2016
TOP STORIES
IDWeek 2016: Not-to-Miss Sessions Featuring the Latest on the Zika Outbreak

IDWeek 2016 promises to be a great educational opportunity for professionals to hear first-hand accounts from experts managing current infectious diseases outbreaks, with a special emphasis this year on the ongoing Zika epidemic. Learn about the newest diagnostic and treatment modalities; apply state-of-the-art science to clinical care; and network with colleagues from around the world.

The following sessions will focus on the effects of Zika and what clinicians need to know to help their patients:

Zika Zymposium I: Epidemiology, Virology, and Countermeasures will be held on Wednesday, Oct. 26 from 1:30 to 2:30 p.m. and will feature presentations from Lyle Petersen, MD, MPH, with the Centers for Disease Control and Prevention; Helen Lazear, PhD, from the University of North Carolina School of Medicine; and Mark Mulligan, MD, FIDSA, with the Hope Clinic at Emory University.

Later that same day, during the Opening Plenary from 3:45 p.m. to 5:45 p.m., there will be a presentation from the front lines titled “Zika Virus: New Lessons and Future Challenges from an Area of Endemicity” from Mauro Schecter, MD, PhD, with the Projeto Praça Onze in Rio de Janeiro, Brazil.

Finally, Zika Zymposium II: Post-Infectious Sequelae and Clinical Guidance will take place on Friday, Oct. 28 from 2:00 to 3:30 p.m.

Register now to attend any or all of these invigorating sessions.

For further session information, view the Interactive Program.

And be sure to attend the Town Hall: Securing the Future of ID on Friday, Oct. 28, from 6:00 to 7:30 p.m.

Important Dates:

Advanced Registration

September 23

Full Abstract Text Available*

October 12

*Findings in the abstracts are embargoed until 12:01 a.m. CDT, Wednesday Oct. 26th with the exception of research findings presented at the IDWeek press conferences.

< Previous Article | Next Article >

Post a comment

Your name:

Your comment:


PATIENT CARE AND SCIENCE
Updated IDSA Guideline on Valley Fever Published in CID
Drug-Susceptible Tuberculosis Guidelines Now Available
Updated Guideline on Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia Now Available
HCV Guidance Website Updated to Reflect Latest Drug Developments
IDSA Partners with AGA on New Registry to Track Fecal Microbiota Transplants
CLSI Updates on Antimicrobial Susceptibility Testing Are Now Available
CDC Issues Travel Warning for Area in Miami Due to Locally Transmitted Zika Virus; Generic Version of Tamiflu Approved by FDA
CLINICAL PRACTICE MANAGEMENT
Virtual Supervision of “Incident To” Services
POLICY AND ADVOCACY
Take 3 Minutes to Tell the UN to Take Global Action on Antimicrobial Resistance
As US Cases Mount, IDSA Continues To Push for Zika Funding
Massachusetts Passes Troubling Lyme Legislation
Party Platforms Include IDSA Priorities
GLOBAL HEALTH
Live from Durban: Science Speaks Covers AIDS 2016
EDUCATION AND RESOURCES
Stipends Available to ID Medical Student Interest Groups
Vaccines Virtual Collection from CID
Upcoming Webinar on Antibiotic Drug Development
YOU AND YOUR COLLEAGUES
IDSA, HIVMA Seek Clinical Practice Guidelines Editor
FROM THE PRESIDENT
IDSA Advocacy on ID-Led Stewardship—More Progress on our Strategic Priorities
TOP STORIES
Don’t Miss These IDSA Guidelines Updates
IDSA Honors 111 Distinguished Physicians, Scientists with FIDSA
IDWeek 2016: Not-to-Miss Sessions Featuring the Latest on the Zika Outbreak
Journal Club
IDSA | 1300 Wilson Blvd., Suite 300 | Arlington, VA 22209 | Phone: (703) 299-0200
To ensure delivery, please add 'info@idsociety.org' to your email address book or Safe Sender List.
If you are still having problems receiving our communications,
see our white-listing page for more details.